Troglitazone activates p21Cip/WAF1 through the ERK pathway in HCT15 human colorectal cancer cells

MLA

Jong Won Oh, et al. “Troglitazone Activates P21Cip/WAF1 through the ERK Pathway in HCT15 Human Colorectal Cancer Cells.” Cancer Letters, vol. 179, no. 2, Mar. 2002. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....822a1bc36b299b48a6d046d66c966bea&authtype=sso&custid=ns315887.

APA

Jong Won Oh, Kang Yell Choi, Ki-Sook Park, Ha Il Kim, Jin Ah Kim, Yong-Ho Ahn, & So Young Oh. (2002). Troglitazone activates p21Cip/WAF1 through the ERK pathway in HCT15 human colorectal cancer cells. Cancer Letters, 179(2).

Chicago

Jong Won Oh, Kang Yell Choi, Ki-Sook Park, Ha Il Kim, Jin Ah Kim, Yong-Ho Ahn, and So Young Oh. 2002. “Troglitazone Activates P21Cip/WAF1 through the ERK Pathway in HCT15 Human Colorectal Cancer Cells.” Cancer Letters 179 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....822a1bc36b299b48a6d046d66c966bea&authtype=sso&custid=ns315887.